Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay

Journal of Clinical Microbiology

Volumn 49, Issue 12, 2011, Pages 4273-4278

  Torelli, Riccardo ^a   Sanguinetti, Maurizio ^a   Moody, Adrian ^b   Pagano, Livio ^a   Caira, Morena ^a   De Carolis, Elena ^a   Fuso, Leonello ^a   De Pascale, Gennaro ^a   Bello, Giuseppe ^a   Antonelli, Massimo ^a   Fadda, Giovanni ^a   Posteraro, Brunella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Myconostica Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ECHINOCANDIN; FUNGAL DNA; GALACTOMANNAN; POLYENE;

ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS GLAUCUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FUNGUS CULTURE; FUSARIOSIS; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ASPERGILLUS; BACTERIOLOGICAL TECHNIQUES; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; IMMUNOENZYME TECHNIQUES; MANNANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PROSPECTIVE STUDIES; PULMONARY ASPERGILLOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 82455220443     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05026-11     Document Type: Article

References (45)

1. Almyroudis, N. G., and B. H. Segal. 2009. Prevention and treatment of invasive fungal diseases in neutropenic patients. Curr. Opin. Infect. Dis. 22:385-393.
2. Balajee, S. A., et al. 2009. Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J. Clin. Microbiol. 47:877-884.
3. Becker, M. J., et al. 2003. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br. J. Haematol. 121:448-457. (Pubitemid 36628336)
4. Bergeron, A., et al. 2010. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 137:410-415.
5. Botterel, F., et al. 2008. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients. Transpl. Infect. Dis. 10:333-338.
6. Boudewijns, M., P. E. Verweij, and W. J. Melchers. 2006. Molecular diagnosis of invasive aspergillosis: the long and winding road. Future Microbiol. 1:283-293.
7. Cuenca-Estrella, M., et al. 2011. Detection and investigation of invasive mould disease. J. Antimicrob. Chemother. 66:i15-i24.
8. de Hoog, G. S., J. Guarro, J. Gené, and M. J. Figueras. 2000. Atlas of clinical fungi. Centraalbureau voor Schimmelcultures, Utrecht, Netherlands.
9. Denning, D. W., et al. 2011. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 52:1123-1129.
10. De Pauw, B., et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
11. Donnelly, J. P. 2006. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin. Infect. Dis. 42:487-489. (Pubitemid 43202520)
12. Greub, G., and J. Bille. 1998. Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance. Clin. Microbiol. Infect. 4:710-716. (Pubitemid 29020864)
13. Guo, Y. L., et al. 2010. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest 138:817-824.
14. Hadrich, I., et al. 2011. Comparison of PCR-ELISA and real-time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies. Med. Mycol. 49:489-494.
15. Hage, C. A., K. S. Knox, T. E. Davis, and L. J. Wheat. 2011. Antigen detection in bronchoalveolar lavage fluid for diagnosis of fungal pneumonia. Curr. Opin. Pulm. Med. 17:167-171.
16. Hidalgo, A., et al. 2009. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis. Eur. J. Radiol. 71:55-60.
17. Hope, W. W., T. J. Walsh, and D. W. Denning. 2005. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5:609-622. (Pubitemid 41383906)
18. Hummel, M., et al. 2010. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial. Eur. J. Haematol. 85:164-169.
19. Husain, S., et al. 2008. Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin. Vaccine Immunol. 15:1760-1763.
20. Khot, P. D., and D. N. Fredricks. 2009. PCR-based diagnosis of human fungal infections. Expert Rev. Anti Infect. Ther. 7:1201-1221.
21. Khot, P. D., D. L. Ko, R. C. Hackman, and D. N. Fredricks. 2008. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect. Dis. 8:73.
22. Knox, K. S., and L. Meinke. 2009. Role of bronchoalveolar lavage diagnostics in fungal infections. Clin. Chest Med. 30:355-365.
23. Kontoyiannis, D. P., and G. P. Bodey. 2002. Invasive aspergillosis in 2002: an update. Eur. J. Clin. Microbiol. Infect. Dis. 21:161-172.
24. Lass-Flörl, C., et al. 2004. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J. Clin. Microbiol. 42:4154-4157. (Pubitemid 39296138)
25. Luong, M. L., et al. 2011. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin. Infect. Dis. 52:1218-1226.
26. Lyratzopoulos, G., M. Ellis, R. Nerringer, and D. W. Denning. 2002. Invasive infection due to Penicillium species other than P. marneffei. J. Infect. 45:184-195.
27. Maertens, J., et al. 2009. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49:1688-1693.
28. Marr, K. A., M. Laverdiere, A. Gugel, and W. Leisenring. 2005. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40:1762-1769. (Pubitemid 40799945)
29. Marty, F. M., and S. Koo. 2009. Role of (133)-beta-D-glucan in the diagnosis of invasive aspergillosis. Med. Mycol. 47:S233-S240.
30. Meersseman, W., K. Lagrou, J. Maertens, and E. Van Wijngaerden. 2007. Invasive aspergillosis in the intensive care unit. Clin. Infect. Dis. 45:205-216. (Pubitemid 47044802)
31. Meersseman, W., et al. 2008. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am. J. Respir. Crit. Care Med. 177:27-34.
32. Mengoli, C., M. Cruciani, R. A. Barnes, J. Loeffler, and J. P. Donnelly. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9:89-96.
33. Mennink-Kersten, M. A., J. P. Donnelly, and P. E. Verweij. 2004. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4:349-357. (Pubitemid 38692699)
34. Millon, L., et al. 2010. False-positive Aspergillus real-time PCR assay due to a nutritional supplement in a bone marrow transplant recipient with GVH disease. Med. Mycol. 48:661-664.
35. Myconostica, Ltd. 2010. MycAssay Aspergillus Cepheid SmartCycler-Serum. Instructions for use 080-045, version 1. Myconostica, Manchester, United Kingdom.
36. Pagano, L., et al. 2010. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica 95:644-650.
37. Pfeiffer, C. D., J. P. Fine, and N. Safdar. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42:1417-1427.
38. Rex, J. H. 2006. Galactomannan and the diagnosis of invasive aspergillosis. Clin. Infect. Dis. 42:1428-1430.
39. Rüping, M. J., J. J. Vehreschild, and O. A. Cornely. 2008. Patients at high risk of invasive fungal infections: when and how to treat. Drugs 68:1941-1962.
40. Sanguinetti, M., et al. 2003. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J. Clin. Microbiol. 41:3922-3925. (Pubitemid 36994742)
41. Segal, B. H., and T. J. Walsh. 2006. Current approaches to diagnosis and treatment of invasive aspergillosis. Am. J. Respir. Crit. Care Med. 173:707-717.
42. Tuon, F. F. 2007. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev. Iberoam. Micol. 24:89-94. (Pubitemid 47025141)
43. White, P. L., et al. 2010. Aspergillus PCR: one step closer to standardization. J. Clin. Microbiol. 48:1231-1240.
44. White, P. L., et al. 2011. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 49:2169-2174.
45. Yeo, S. F., and B. Wong. 2002. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev. 15:465-484. (Pubitemid 34761353)